Evaluation of Allergenic, Immunogenic, and Skin-Irritant Effects of Deicing Chemicals in Warm-Blooded Animals


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We studied allergenic, immunogenic, and skin-irritating effects of deicing chemicals HCM (Volgograd), Bishofit (Turkmenia), and Nordix-P (Russia) in model experiments on various types of laboratory animals (rats, mice, rabbits). All the studied deicing chemicals exhibited weak immunotoxic activity and in high doses can cause delayed-type hypersensitivity reaction that manifested in skin irritant effect on the skin and produced a suppressive effect on the humoral immunity. The modified method for assessing skin irritation proposed by us is more sensitive than standard methods.

About the authors

M. A. Vodyanova

Center for Strategic Planning and Management of Biomedical Health Risks, Ministry of Health of the Russian Federation

Author for correspondence.
Email: lab.pochva@mail.ru
Russian Federation, Moscow

I. A. Kryatov

Center for Strategic Planning and Management of Biomedical Health Risks, Ministry of Health of the Russian Federation

Email: lab.pochva@mail.ru
Russian Federation, Moscow

S. B. Chudakova

Center for Strategic Planning and Management of Biomedical Health Risks, Ministry of Health of the Russian Federation

Email: lab.pochva@mail.ru
Russian Federation, Moscow

O. V. Ushakova

Center for Strategic Planning and Management of Biomedical Health Risks, Ministry of Health of the Russian Federation

Email: lab.pochva@mail.ru
Russian Federation, Moscow

I. S. Evseeva

Center for Strategic Planning and Management of Biomedical Health Risks, Ministry of Health of the Russian Federation

Email: lab.pochva@mail.ru
Russian Federation, Moscow

A. K. Makovetskaya

Center for Strategic Planning and Management of Biomedical Health Risks, Ministry of Health of the Russian Federation

Email: lab.pochva@mail.ru
Russian Federation, Moscow

O. V. Mislavsky

Center for Strategic Planning and Management of Biomedical Health Risks, Ministry of Health of the Russian Federation

Email: lab.pochva@mail.ru
Russian Federation, Moscow


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies